Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2021 | 08-2020 | 08-2019 | 08-2018 | 08-2017 | |
| Sales | 4,004,863 | 4,019,525 | 4,010,725 | 4,026,302 | 4,061,200 |
| Cost of Goods | 3,510,342 | 3,545,031 | 3,492,420 | 3,529,592 | 3,567,817 |
| Gross Profit | 494,521 | 474,494 | 518,305 | 496,710 | 493,383 |
| Operating Expenses | 561,011 | 534,540 | 480,853 | 451,379 | 438,692 |
| Operating Income | -66,490 | -60,046 | 37,452 | 45,331 | 54,691 |
| Interest Expense | 10,121 | 13,323 | 20,649 | 12,441 | 12,928 |
| Other Income | 89,074 | 58,722 | 56,937 | 37,137 | 34,649 |
| Pre-tax Income | 12,463 | -14,647 | 73,740 | 70,027 | 76,412 |
| Income Tax | 11,317 | -6,710 | 17,163 | 21,825 | 24,041 |
| Net Income Continuous | 1,146 | -7,937 | 56,577 | 48,202 | 52,371 |
| Minority Interests | 231 | -458 | -1,468 | -146 | N/A |
| Net Income | $1,377 | $-8,395 | $55,109 | $48,056 | $52,371 |
| EPS Basic Total Ops | 0.00 | -0.02 | 0.11 | 0.10 | 0.11 |
| EPS Basic Continuous Ops | 0.00 | -0.02 | 0.11 | 0.10 | 0.11 |
| EPS Diluted Total Ops | 0.00 | -0.02 | 0.11 | 0.10 | 0.11 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | 0.11 | 0.10 | 0.11 |
| EBITDA(a) | $110,922 | $86,184 | $123,458 | $110,644 | $117,964 |